Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study JF Liu, WT Barry, M Birrer, JM Lee, RJ Buckanovich, GF Fleming, ... The Lancet Oncology 15 (11), 1207-1214, 2014 | 615 | 2014 |
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy RJ Buckanovich, A Facciabene, S Kim, F Benencia, D Sasaroli, K Balint, ... Nature medicine 14 (1), 28-36, 2008 | 586 | 2008 |
Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A JR Conejo-Garcia, F Benencia, MC Courreges, E Kang, ... Nature medicine 10 (9), 950-958, 2004 | 575 | 2004 |
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival IA Silva, S Bai, K McLean, K Yang, K Griffith, D Thomas, C Ginestier, ... Cancer research 71 (11), 3991-4001, 2011 | 572 | 2011 |
Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability KB Jensen, BK Dredge, G Stefani, R Zhong, RJ Buckanovich, HJ Okano, ... Neuron 25 (2), 359-371, 2000 | 521 | 2000 |
Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system RJ Buckanovich, JB Posner, RB Darnell Neuron 11 (4), 657-672, 1993 | 392 | 1993 |
Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production K McLean, Y Gong, Y Choi, N Deng, K Yang, S Bai, L Cabrera, E Keller, ... The Journal of clinical investigation 121 (8), 3206-3219, 2011 | 382 | 2011 |
The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo RJ Buckanovich, RB Darnell Molecular and cellular biology, 1997 | 330 | 1997 |
Tumor vascular proteins as biomarkers in ovarian cancer RJ Buckanovich, D Sasaroli, A O'Brien-Jenkins, J Botbyl, R Hammond, ... Journal of clinical oncology 25 (7), 852-861, 2007 | 237 | 2007 |
Vascular leukocytes contribute to tumor vascularization JR Conejo-Garcia, RJ Buckanovich, F Benencia, MC Courreges, ... Blood 105 (2), 679-681, 2005 | 237 | 2005 |
Metformin targets ovarian cancer stem cells in vitro and in vivo JJ Shank, K Yang, J Ghannam, L Cabrera, CJ Johnston, RK Reynolds, ... Gynecologic oncology 127 (2), 390-397, 2012 | 232 | 2012 |
The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies RJ Buckanovich, YY Yang, RB Darnell Journal of Neuroscience 16 (3), 1114-1122, 1996 | 232 | 1996 |
Ovarian cancer stem cell markers: prognostic and therapeutic implications D Burgos-Ojeda, BR Rueda, RJ Buckanovich Cancer letters 322 (1), 1-7, 2012 | 194 | 2012 |
Single-cell migration chip for chemotaxis-based microfluidic selection of heterogeneous cell populations YC Chen, SG Allen, PN Ingram, R Buckanovich, SD Merajver, E Yoon Scientific reports 5 (1), 9980, 2015 | 174 | 2015 |
Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity E Huarte, JR Cubillos-Ruiz, YC Nesbeth, UK Scarlett, DG Martinez, ... Cancer research 68 (18), 7684-7691, 2008 | 171 | 2008 |
Transcriptional coactivator Drosophila eyes absent homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth L Zhang, N Yang, J Huang, RJ Buckanovich, S Liang, A Barchetti, ... Cancer research 65 (3), 925-932, 2005 | 171 | 2005 |
The double edge sword of fibrosis in cancer C Chandler, T Liu, R Buckanovich, LG Coffman Translational Research 209, 55-67, 2019 | 153 | 2019 |
Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum … JF Liu, WT Barry, M Birrer, JM Lee, RJ Buckanovich, GF Fleming, ... Annals of Oncology 30 (4), 551-557, 2019 | 152 | 2019 |
Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays S Raghavan, MR Ward, KR Rowley, RM Wold, S Takayama, ... Gynecologic oncology 138 (1), 181-189, 2015 | 149 | 2015 |
Ovarian cancer stem cells: working towards the root of stemness R Foster, RJ Buckanovich, BR Rueda Cancer letters 338 (1), 147-157, 2013 | 149 | 2013 |